• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者脑转移的预测因素。

Predictive factors of brain metastasis in patients with breast cancer.

机构信息

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Med Oncol. 2013 Mar;30(1):337. doi: 10.1007/s12032-012-0337-2. Epub 2013 Feb 12.

DOI:10.1007/s12032-012-0337-2
PMID:23400960
Abstract

The aim of this study is to determine the risk factors associated with metastasis to the brain of primary breast cancer patients and evaluate a predictive model. The clinicopathological characteristics of 206 patients with primary breast cancer were analyzed retrospectively with a univariate and multivariate logistic regression model. A predictive model was generated, and its validity evaluated with a receiver operating characteristic (ROC) curve. Independent risk factors for brain metastasis in patients with primary breast cancer were: being younger than 35 years old at the time of diagnosis, having four or more metastatic axillary nodes, being estrogen receptor-negative, and with 24 months of metastasis-free survival. The predictive value of the brain metastasis risk model, measured as the area under the ROC curve, was 0.765 ± 0.040 (95 % CI 0.688-0.842). When 0.8 was considered the cutoff point of probability calculated by the model, the sensitivity and specificity for predicting the occurrence of brain metastases in these patients were 0.769 and 0.713, respectively. The predictive model constructed in this study can be used to forecast brain metastasis in breast cancer. Patients with a predictive level ≥0.8 could be treated preventively for brain metastases.

摘要

本研究旨在确定与原发性乳腺癌患者脑转移相关的风险因素,并评估预测模型。回顾性分析了 206 例原发性乳腺癌患者的临床病理特征,采用单因素和多因素逻辑回归模型进行分析。生成了预测模型,并通过接收者操作特征(ROC)曲线评估其有效性。原发性乳腺癌患者脑转移的独立危险因素为:诊断时年龄小于 35 岁、腋窝转移淋巴结 4 个或以上、雌激素受体阴性以及无转移生存时间 24 个月。ROC 曲线下面积(AUC)衡量脑转移风险模型的预测价值,为 0.765±0.040(95%CI 0.688-0.842)。当模型计算的概率截断值为 0.8 时,预测这些患者发生脑转移的敏感性和特异性分别为 0.769 和 0.713。本研究构建的预测模型可用于预测乳腺癌脑转移。预测值≥0.8 的患者可预防性地进行脑转移治疗。

相似文献

1
Predictive factors of brain metastasis in patients with breast cancer.乳腺癌患者脑转移的预测因素。
Med Oncol. 2013 Mar;30(1):337. doi: 10.1007/s12032-012-0337-2. Epub 2013 Feb 12.
2
Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.列线图预测转移性乳腺癌患者的继发脑转移。
J Clin Oncol. 2010 Apr 20;28(12):2032-7. doi: 10.1200/JCO.2009.24.6314. Epub 2010 Mar 22.
3
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.乳腺癌脑转移患者无脑转移间隔的预后价值。
World Neurosurg. 2019 Aug;128:e157-e164. doi: 10.1016/j.wneu.2019.04.072. Epub 2019 Apr 26.
4
Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.雌激素和/或人表皮生长因子受体2阳性与三阴性乳腺癌患者诊断为脑转移后的临床结局。
Ann Oncol. 2008 Sep;19(9):1561-5. doi: 10.1093/annonc/mdn283. Epub 2008 Jun 5.
5
Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.乳腺癌患者前哨淋巴结转移的危险因素及 MSKCC 列线图的验证研究。
Jpn J Clin Oncol. 2012 Nov;42(11):1002-7. doi: 10.1093/jjco/hys150.
6
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.肿瘤亚型对乳腺癌脑转移患者生存的影响及分级预后评估。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2111-7. doi: 10.1016/j.ijrobp.2011.02.027. Epub 2011 Apr 15.
7
Identifying risk factors for brain metastasis in breast cancer patients: Implication for a vigorous surveillance program.确定乳腺癌患者脑转移的风险因素:对积极监测方案的意义。
Asian J Surg. 2015 Oct;38(4):220-3. doi: 10.1016/j.asjsur.2015.03.003. Epub 2015 Jul 26.
8
Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.诊断时患有乳腺癌和脑转移的患者的预后因素和生存结果:国家癌症数据库分析。
Oncology. 2021;99(5):280-291. doi: 10.1159/000512212. Epub 2021 Mar 2.
9
Predicting axillary sentinel node status in patients with primary breast cancer.预测原发性乳腺癌患者腋窝前哨淋巴结状态。
Neoplasma. 2013;60(3):334-42. doi: 10.4149/neo_2013_045.
10
The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.18F-FDG PET/CT中转移灶的最大标准化摄取值可预测转移性乳腺癌的分子亚型和生存情况:伊兹密尔肿瘤学组研究
J BUON. 2016 Nov-Dec;21(6):1410-1418.

引用本文的文献

1
Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.开发和外部验证转移性乳腺癌患者脑转移预测模型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12333-12353. doi: 10.1007/s00432-023-05125-y. Epub 2023 Jul 11.
2
Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases.乳腺癌脑转移新型潜在生物标志物的筛选与鉴定
Front Oncol. 2022 Jan 13;11:784096. doi: 10.3389/fonc.2021.784096. eCollection 2021.
3
A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer.

本文引用的文献

1
Cancer treatment and survivorship statistics, 2012.癌症治疗与生存统计,2012 年。
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41. doi: 10.3322/caac.21149. Epub 2012 Jun 14.
2
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
3
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.曲妥珠单抗治疗的 HER-2+晚期乳腺癌患者定量 HER-2 蛋白表达与脑转移风险的相关性。
一种用于预测初诊IV期乳腺癌患者脑转移的列线图。
Ann Transl Med. 2021 May;9(10):853. doi: 10.21037/atm-21-1808.
4
Sex steroid hormone function in the brain niche: Implications for brain metastatic colonization and progression.脑微环境中的性激素功能:对脑转移定植和进展的影响。
Cancer Rep (Hoboken). 2022 Apr;5(4):e1241. doi: 10.1002/cnr2.1241. Epub 2020 Mar 3.
5
Risk factors for breast cancer brain metastases: a systematic review.乳腺癌脑转移的危险因素:一项系统综述。
Oncotarget. 2020 Feb 11;11(6):650-669. doi: 10.18632/oncotarget.27453.
6
Apparent diffusion coefficient histogram in breast cancer brain metastases may predict their biological subtype and progression.乳腺癌脑转移的表观扩散系数直方图可预测其生物学亚型和进展。
Sci Rep. 2018 Jul 2;8(1):9947. doi: 10.1038/s41598-018-28315-y.
7
Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes.脑转移瘤的局部控制:与亚型相关的局灶性脑部治疗的治疗结果。
J Breast Cancer. 2015 Mar;18(1):29-35. doi: 10.4048/jbc.2015.18.1.29. Epub 2015 Mar 27.
8
Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases.全身治疗对脑转移瘤患者全脑放疗后生存的影响。
Med Oncol. 2014 Apr;31(4):927. doi: 10.1007/s12032-014-0927-2. Epub 2014 Mar 20.
9
Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.曲妥珠单抗治疗 HER2 阳性乳腺癌脑转移的研究进展
Med Oncol. 2014 Feb;31(2):832. doi: 10.1007/s12032-013-0832-0. Epub 2014 Jan 5.
10
Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases.Ⅱ期随机、双盲、安慰剂对照研究全脑放疗联合氯喹治疗脑转移瘤。
Radiat Oncol. 2013 Sep 8;8:209. doi: 10.1186/1748-717X-8-209.
Oncologist. 2012;17(1):26-35. doi: 10.1634/theoncologist.2011-0212. Epub 2012 Jan 10.
4
Effect of occult metastases on survival in node-negative breast cancer.隐匿性转移对无淋巴结转移乳腺癌患者生存的影响。
N Engl J Med. 2011 Feb 3;364(5):412-21. doi: 10.1056/NEJMoa1008108. Epub 2011 Jan 19.
5
A tiny step closer to personalized risk prediction for breast cancer.离乳腺癌的个性化风险预测又近了一小步。
N Engl J Med. 2010 Mar 18;362(11):1043-5. doi: 10.1056/NEJMe0912474.
6
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.循环 microRNAs 作为乳腺癌新型微创生物标志物。
Ann Surg. 2010 Mar;251(3):499-505. doi: 10.1097/SLA.0b013e3181cc939f.
7
Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?乳腺癌患者的激素与放疗联合治疗:其理论依据是什么?
Lancet Oncol. 2009 Jan;10(1):53-60. doi: 10.1016/S1470-2045(08)70333-4.
8
Polygenes, risk prediction, and targeted prevention of breast cancer.多基因、风险预测与乳腺癌的靶向预防
N Engl J Med. 2008 Jun 26;358(26):2796-803. doi: 10.1056/NEJMsa0708739.
9
Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis.乳腺癌表面受体可预测发生脑转移的风险及后续预后。
Breast Cancer Res. 2008;10(2):104. doi: 10.1186/bcr1868. Epub 2008 Mar 14.
10
Breast cancer brain metastases.乳腺癌脑转移
Cancer Metastasis Rev. 2007 Dec;26(3-4):635-43. doi: 10.1007/s10555-007-9083-x.